Eudmar Marcolino

Dr. Eudmar Marcolino

Genomics Laboratory, Birmingham Women’s and Children’s NHS Foundation Trust, Birmingham, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Agriculture, Ecosystems & Environment
Verified
Journal Article
Closed access
Eudmar MarcolinoEudmar Marcolino
Eudmar Marcolino
IFIsmael Malaquias dos Santos Fernandes
Ismael Malaquias dos Santos Fernandes
CSCaio Sérgio Santos
Caio Sérgio Santos
LMLuciene Xavier de Mesquita
Luciene Xavier de Mesquita
RPRogério Aparecido Pereira
Rogério Aparecido Pereira
BSBenito Soto-Blanco
Benito Soto-Blanco

4 February 2020 in Oncogenesis
Verified
Journal Article
Open access
PDF file
Eudmar MarcolinoEudmar Marcolino
Eudmar Marcolino
YSYusra Siddiqui
Yusra Siddiqui
MBMarion van Den Bosch
Marion van Den Bosch
APAlastair Poole
Alastair Poole
PJPadma-Sheela Jayaraman
Padma-Sheela Jayaraman
Kevin GastonKevin Gaston
Kevin Gaston
Cancer cells go through a process known as epithelial–mesenchymal transition (EMT) during which they acquire the ability to migrate and invade extracellular matrix. Some cells also acquire the ability to move across a layer of endothelial cells to enter and exit the bloodstream; intra- and extravasation, respectively. The transcription factor PRH/HHEX (proline-rich homeodomain/haematopoietically expressed homeobox) controls cell proliferation and cell migration/invasion in a range of cell types. Our previous work showed that PRH activity is downregulated in prostate cancer cells owing to increased inhibitory PRH phosphorylation and that this increases cell proliferation and invasion. PRH inhibits migration and invasion by prostate and breast epithelial cells in part by activating the transcription of Endoglin, a transforming growth factor β (TGFβ) co-receptor. Here we show that depletion of PRH in immortalised prostate epithelial cells results in increased extravasation in vitro. We show that blood platelets stimulate extravasation of cells with depleted PRH and that inhibition of TGFβ signalling blocks the effects of platelets on these cells. Moreover, TGFβ induces changes characteristic of EMT including decreased E-Cadherin expression and increased Snail expression. We show that in prostate cells PRH regulates multiple genes involved in EMT and TGFβ signalling. However, both platelets and TGFβ increase PRH phosphorylation. In addition, TGFβ increases binding of its effector pSMAD3 to the PRH/HHEX promoter and downregulates PRH protein and mRNA levels. Thus, TGFβ signalling downregulates PRH activity by multiple mechanisms and induces an EMT that facilitates extravasation and sensitises cells to TGFβ.

1 August 2014 in Nitric Oxide
Verified
Journal Article
Closed access
RSRenan O. Silva
Renan O. Silva
LLLarisse T. Lucetti
Larisse T. Lucetti
DWDeysi V.T. Wong
Deysi V.T. Wong
KAKaroline S. Aragão
Karoline S. Aragão
Eudmar MarcolinoEudmar Marcolino
Eudmar Marcolino
JMJand Medeiros
Jand Medeiros

14 December 2015 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
VPVenúcia B. M. Pereira
Venúcia B. M. Pereira
AMAnielle T. Melo
Anielle T. Melo
Eudmar MarcolinoEudmar Marcolino
Eudmar Marcolino
DWDeysi V. T. Wong
Deysi V. T. Wong
GBGerly Brito
Gerly Brito
Roberto Lima-JúniorRoberto Lima-Júnior
Roberto Lima-Júnior

1 July 2017 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
Eudmar MarcolinoEudmar Marcolino
Eudmar Marcolino
AMAnielle Torres Melo
Anielle Torres Melo
VPVenúcia Bruna Magalhães Pereira
Venúcia Bruna Magalhães Pereira
DWDeysi Viviana Tenazoa Wong
Deysi Viviana Tenazoa Wong
NSNathalia Ribeiro Pinho Sousa
Nathalia Ribeiro Pinho Sousa
Roberto Lima-JúniorRoberto Lima-Júnior
Roberto Lima-Júnior

30 January 2017 in Oncogenesis
Verified
Journal Article
Open access
PDF file
YSYusra Siddiqui
Yusra Siddiqui
RKR M Kershaw
R M Kershaw
EHE H Humphreys
E H Humphreys
Eudmar MarcolinoEudmar Marcolino
Eudmar Marcolino
SCS Chaudhri
S Chaudhri
Kevin GastonKevin Gaston
Kevin Gaston
PRH/HHEX (proline-rich homeodomain protein/haematopoietically expressed homeobox protein) is a transcription factor that controls cell proliferation, cell differentiation and cell migration. Our previous work has shown that in haematopoietic cells, Protein Kinase CK2-dependent phosphorylation of PRH results in the inhibition of PRH DNA-binding activity, increased cleavage of PRH by the proteasome and the misregulation of PRH target genes. Here we show that PRH and hyper-phosphorylated PRH are present in normal prostate epithelial cells, and that hyper-phosphorylated PRH levels are elevated in benign prostatic hyperplasia, prostatic adenocarcinoma, and prostate cancer cell lines. A reduction in PRH protein levels increases the motility of normal prostate epithelial cells and conversely, PRH over-expression inhibits prostate cancer cell migration and blocks the ability of these cells to invade an extracellular matrix. We show that CK2 over-expression blocks the repression of prostate cancer cell migration and invasion by PRH. In addition, we show that PRH knockdown in normal immortalised prostate cells results in an increase in the population of cells capable of colony formation in Matrigel, as well as increased cell invasion and decreased E-cadherin expression. Inhibition of CK2 reduces PRH phosphorylation and reduces prostate cell proliferation but the effects of CK2 inhibition on cell proliferation are abrogated in PRH knockdown cells. These data suggest that the increased phosphorylation of PRH in prostate cancer cells increases both cell proliferation and tumour cell migration/invasion.